N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2004

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

etoposide

DRUG

melphalan

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

iobenguane I 131

RADIATION

radiation therapy

Trial Locations (15)

19104

Children's Hospital of Philadelphia, Philadelphia

30322

AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta

60614

Children's Memorial Hospital - Chicago, Chicago

94143

UCSF Comprehensive Cancer Center, San Francisco

94304

Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

90027-0700

Children's Hospital Los Angeles, Los Angeles

46202-5289

Indiana University Cancer Center, Indianapolis

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

02115

Children's Hospital Boston, Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

48109-0914

University of Michigan Comprehensive Cancer Center, Ann Arbor

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

77030-2399

Texas Children's Cancer Center, Houston

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

New Approaches to Neuroblastoma Therapy Consortium

OTHER

NCT00005978 - N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | Biotech Hunter | Biotech Hunter